Authors:
Da'as, N
Polliack, A
Cohen, Y
Amir, G
Darmon, D
Kleinman, Y
Goldfarb, AW
Ben-Yehuda, D
Citation: N. Da'As et al., Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients, EUR J HAEMA, 67(3), 2001, pp. 158-164
Citation: S. Gillis et al., Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapy, EUR J HAEMA, 66(1), 2001, pp. 7-10
Authors:
Da'as, N
Kleinman, Y
Polliack, A
Amir, G
Ne'eman, Z
Kopolovic, J
Bits, H
Darmon, D
Citation: N. Da'As et al., Immunotactoid glomerulopathy with massive bone marrow deposits in a patient with IgM kappa monoclonal gammopathy and hypocomplementemia, AM J KIDNEY, 38(2), 2001, pp. 395-399
Authors:
Ashhab, Y
Alian, A
Polliack, A
Panet, A
Ben Yehuda, D
Citation: Y. Ashhab et al., Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern, FEBS LETTER, 495(1-2), 2001, pp. 56-60
Authors:
Or, R
Weiss, L
Amir, G
Tejman, S
Polliack, A
Citation: R. Or et al., The prophylactic potential of fludarabine monophosphate in graft-versus-host disease after bone marrow transplantation in murine models, BONE MAR TR, 25(3), 2000, pp. 263-266
Authors:
Paltiel, O
Schmit, T
Adler, B
Rachmilevitz, EA
Polliack, A
Cohen, A
Haim, N
Ben Shachar, M
Epelbaum, R
Barchana, M
Cohen, R
Ben Yehuda, D
Citation: O. Paltiel et al., The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-hodgkin lymphoma - Results and limitations of a registry-linked study, CANCER, 88(10), 2000, pp. 2357-2366
Citation: Is. Lossos et al., Salvage chemotherapy using a combination of fludarabine and cyclophosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas, LEUK LYMPH, 33(1-2), 1999, pp. 155-160
Citation: V. Barak et al., The tumor necrosis factor family and correlation with disease activity andresponse to treatment in hairy cell leukemia, EUR J HAEMA, 62(2), 1999, pp. 71-75
Authors:
Asimakopoulos, FA
Shteper, PJ
Krichevsky, S
Fibach, E
Polliack, A
Rachmilewitz, E
Ben-Neriah, Y
Ben-Yehuda, D
Citation: Fa. Asimakopoulos et al., ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia, BLOOD, 94(7), 1999, pp. 2452-2460